Jialong Zhu

机构：Nanjing General Hospital of Nanjing Military Command, Nanjing University · ORCID：0009-0003-2165-8135

发表论文 23 篇 · 总被引 354 次 · h-index 5

代表论文

• The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection (2014 · Journal of Medicinal Chemistry · 被引 112)
• Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity (2025 · Cell Death Discovery · 被引 91)
• Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection (2014 · Journal of Medicinal Chemistry · 被引 70)
• scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20+ B cells (2024 · Cancer Letters · 被引 51)
• Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials (2024 · Journal of Translational Medicine · 被引 14)
• Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus (2016 · Bioorganic & Medicinal Chemistry Letters · 被引 5)